Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rudack

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Allergy|March 10, 1998
The role of cytokines in infectious sinusitis and nasal polyposisC Bachert, M Wagenmann, C Rudack, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 22, 2007
PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epitheliumC Rudack, M Steinhoff, F Mooren, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 3, 2014
Inhibition-induced plasticity in tinnitus patients after repetitive exposure to tailor-made notched musicA Stein, A Engell, M Junghoefer, et al.
Advances in Therapy|February 15, 2011
Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitisR Mösges, C Bachert, C Rudack, et al.
Allergy|March 26, 2003
An update on the diagnosis and treatment of sinusitis and nasal polyposisC Bachert, K Hörmann, R Mösges, et al.
HNO|September 7, 2007
[Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery]B A Stuck, C Bachert, P Federspil, et al.
HNO|December 6, 2011
[Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery]B A Stuck, C Bachert, P Federspil, et al.
Laryngo- Rhino- Otologie|April 2, 2020
, L Klimek, U Förster-Ruhrmann, et al.
HNO|December 29, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)]L Klimek, S Becker, B Haxel, et al.
HNO|April 8, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 1: Hypersensitivity reactions of type IVa-c as a correlate to T1, T2, and T3 endotypes]L Klimek, S Becker, B Haxel, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Allergy|March 10, 1998
The role of cytokines in infectious sinusitis and nasal polyposisC Bachert, M Wagenmann, C Rudack, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 22, 2007
PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epitheliumC Rudack, M Steinhoff, F Mooren, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 3, 2014
Inhibition-induced plasticity in tinnitus patients after repetitive exposure to tailor-made notched musicA Stein, A Engell, M Junghoefer, et al.
Advances in Therapy|February 15, 2011
Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitisR Mösges, C Bachert, C Rudack, et al.
Allergy|March 26, 2003
An update on the diagnosis and treatment of sinusitis and nasal polyposisC Bachert, K Hörmann, R Mösges, et al.
HNO|September 7, 2007
[Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery]B A Stuck, C Bachert, P Federspil, et al.
HNO|December 6, 2011
[Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery]B A Stuck, C Bachert, P Federspil, et al.
Laryngo- Rhino- Otologie|April 2, 2020
, L Klimek, U Förster-Ruhrmann, et al.
HNO|December 29, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)]L Klimek, S Becker, B Haxel, et al.
HNO|April 8, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 1: Hypersensitivity reactions of type IVa-c as a correlate to T1, T2, and T3 endotypes]L Klimek, S Becker, B Haxel, et al.
Pageof 7